Active substances propaquizafop, quizalofop-p-ethyl and quizalofop-p-tefuryl have approvals which were originally expiring between 2019 and 2021. Considering that the three substances are ester variants of quizalofop, they share similar properties. Taking into account Implementing Decision C/2016/6104, the hazard properties of quizalofop-p-tefuryl [European Chemicals Agency Committee for Risk Assessment (RAC) Opinion proposing harmonised classification and labelling at EU level of Quizalofop-P-tefuryl. Adopted 3 June 2016.] and the fact that the three substances have important similarities, it is appropriate to group them together in order to align the timing of their assessment and the peer-review process carried out by the European Food Safety Authority. Consequently, the dossiers for the three substances should be submitted to their respective rapporteur Member States within the same time frame.
Recital 3, Regulation (EU) 2017/1530
In forcesince 7 Sep 2017
- celex=32016D6104